GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea

References

• McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med 2010;362:1597–604.
   PubMed Web of Science ®Google Scholar
• Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology 2007;133:985–1001.
   PubMed Web of Science ®Google Scholar
• Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175–86.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter 2008;13:1–6.
   PubMed Web of Science ®Google Scholar
• Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143–53.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection–the Maastricht IV/Florence Consensus Report. Gut 2012;61:646–64.
   PubMed Web of Science ®Google Scholar
• Graham DY, Shiotani A. Which therapy for Helicobacter pylori infection? Gastroenterology 2012;143:10–12.
   PubMedGoogle Scholar
• Hwang TJ, Kim N, Kim HB, Lee BH, Nam RH, Park JH, et al. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol 2010;44:536–43.
   PubMed Web of Science ®Google Scholar
• Miyachi H, Miki I, Aoyama N, Shirasaka D, Matsumoto Y, Toyoda M, et al. Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan. Helicobacter 2006;11:243–9.
   PubMed Web of Science ®Google Scholar
• Lee JW, Kim N, Nam RH, Park JH, Kim JM, Jung HC, et al. Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea. Helicobacter 2011;16:301–10.
   PubMed Web of Science ®Google Scholar
• Yoon H, Kim N, Lee BH, Hwang TJ, Lee DH, Park YS, et al. Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate. Helicobacter 2009;14:77–85.
   PubMed Web of Science ®Google Scholar
• De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010;19:409–14.
   PubMed Web of Science ®Google Scholar
• Vakil N. H. pylori treatment: new wine in old bottles? Am J Gastroenterol 2009;104:26–30.
   PubMed Web of Science ®Google Scholar
• Meyer JM, Silliman NP, Wang W, Siepman NY, Sugg JE, Morris D, et al. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann Intern Med 2002;136:13–24.
   PubMed Web of Science ®Google Scholar
• Maeda S, Yoshida H, Ogura K, Kanai F, Shiratori Y, Omata M. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 1998;43:317–21.
   PubMedGoogle Scholar
• Maeda S, Yoshida H, Matsunaga H, Ogura K, Kawamata O, Shiratori Y, et al. Detection of clarithromycin-resistant Helicobacter pylori strains by a preferential homoduplex formation assay. J Clin Microbiol 2000;38:210–14.
   PubMedGoogle Scholar
• Kim JM, Kim JS, Kim N, Kim YJ, Kim IY, Chee YJ, et al. Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients. J Microbiol Biotechnol 2008;18:1584–9.
   PubMed Web of Science ®Google Scholar
• van Doorn LJ, Glupczynski Y, Kusters JG, Megraud F, Midolo P, Maggi-Solca N, et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001;45:1500–4.
   PubMedGoogle Scholar
• Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004;53:1374–84.
   PubMed Web of Science ®Google Scholar
• Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007;20:280–322.
   PubMed Web of Science ®Google Scholar
• Rimbara E, Noguchi N, Kawai T, Sasatsu M. Fluoroquinolone resistance in Helicobacter pylori: role of mutations at position 87 and 91 of GyrA on the level of resistance and identification of a resistance conferring mutation in GyrB. Helicobacter 2012;17:36–42.
   PubMed Web of Science ®Google Scholar
• Tankovic J, Chaumette-Planckaert MT, Deforges L, Launay N, Le Glaunec JM, Soussy CJ, et al. Routine use of real-time PCR for detection of Helicobacter pylori and of clarithromycin resistance mutations. Gastroenterol Clin Biol 2007;31:792–5.
   PubMed Web of Science ®Google Scholar
• Kawai T, Yamagishi T, Yagi K, Kataoka M, Kawakami K, Sofuni A, et al. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities. J Gastroenterol Hepatol 2008;23:S171–4.
   PubMedGoogle Scholar
• Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C, Deforges L, et al. Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori. J Clin Microbiol 2009;47:3600–7.
   PubMed Web of Science ®Google Scholar
• Miendje Deyi VY, Burette A, Bentatou Z, Maaroufi Y, Bontems P, Lepage P, et al. Practical use of GenoType(R) HelicoDR, a molecular test for Helicobacter pylori detection and susceptibility testing. Diagn Microbiol Infect Dis 2011;70:557–60.
   PubMed Web of Science ®Google Scholar
• Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013;62:34–42.
   PubMed Web of Science ®Google Scholar
• Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006;6:699–709.
   PubMed Web of Science ®Google Scholar
• Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ. Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003;47:3942–4.
   PubMed Web of Science ®Google Scholar
• Kang JM, Kim N, Lee DH, Park YS, Kim YR, Kim JS, et al. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. Helicobacter 2007;12:623–8.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim N, Kim JM, Kim MS, Park JH, Lee MK, et al. Helicobacter pylori genotyping findings from multiple cultured isolates and mucosal biopsy specimens: strain diversities of Helicobacter pylori isolates in individual hosts. Eur J Gastroenterol Hepatol 2009;21:522–8.
   PubMedGoogle Scholar
• De Francesco V, Zullo A, Ierardi E, Giorgio F, Perna F, Hassan C, et al. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrob Chemother 2010;65:327–32.
   PubMed Web of Science ®Google Scholar
• Liu G, Xu X, He L, Ding Z, Gu Y, Zhang J, et al. Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children. Helicobacter 2011;16:356–62.
   PubMedGoogle Scholar
• Yamade M, Sugimoto M, Uotani T, Nishino M, Kodaira C, Furuta T. Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan. J Gastroenterol Hepatol 2011;26:1457–61.
   PubMed Web of Science ®Google Scholar
• Liu M, Douthwaite S. Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA. Antimicrob Agents Chemother 2002;46:1629–33.
   PubMed Web of Science ®Google Scholar
• Webber MA, Piddock LJ. The importance of efflux pumps in bacterial antibiotic resistance. J Antimicrob Chemother 2003;51:9–11.
   PubMed Web of Science ®Google Scholar
• Mamelli L, Prouzet-Mauleon V, Pages JM, Megraud F, Bolla JM. Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. J Antimicrob Chemother 2005;56:491–7.
   PubMed Web of Science ®Google Scholar
• Francesco VD, Zullo A, Hassan C, Giorgio F, Rosania R, Ierardi E. Mechanisms of Helicobacter pylori antibiotic resistance: an updated appraisal. World J Gastrointest Pathophysiol 2011;2:35–41.
   PubMedGoogle Scholar
• Liu ZQ, Zheng PY, Yang PC. Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. World J Gastroenterol 2008;14:5217–22.
   PubMed Web of Science ®Google Scholar
• Hirata K, Suzuki H, Nishizawa T, Tsugawa H, Muraoka H, Saito Y, et al. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori. J Gastroenterol Hepatol 2010;25:S75–9.
   PubMedGoogle Scholar
• Zhang Z, Liu ZQ, Zheng PY, Tang FA, Yang PC. Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori. World J Gastroenterol 2010;16:1279–84.
   PubMed Web of Science ®Google Scholar
• Yakoob J, Jafri W, Abbas Z, Abid S, Naz S, Khan R, et al. Risk factors associated with Helicobacter pylori infection treatment failure in a high prevalence area. Epidemiol Infect 2011;139:581–90.
   PubMed Web of Science ®Google Scholar